{"pub": "chinadaily", "url": "https://language.chinadaily.com.cn/a/201910/28/WS5db67002a310cf3e35573f9d.html", "downloaded_at": "2019-10-28 05:19:58.492142+00:00", "title": "\u57fa\u56e0\u68c0\u6d4b\u7ed3\u679c\u5448\u9634\u6027\uff1f\u8fd9\u53ef\u80fd\u662f\u201c\u865a\u5047\u7684\u5b89\u6170\u201d", "language": "en", "text": "\u968f\u7740\u533b\u7597\u6280\u672f\u7684\u53d1\u5c55\uff0c\u8d8a\u6765\u8d8a\u591a\u7684\u516c\u53f8\u5f00\u5c55\u4e86\u57fa\u56e0\u68c0\u6d4b\u9879\u76ee\uff0c\u901a\u8fc7\u5206\u6790\u53d7\u8bd5\u8005\u63d0\u4f9b\u7684\u751f\u7269\u5b66\u6837\u672c\uff0c\u68c0\u6d4b\u5176\u57fa\u56e0\u53d8\u5f02\uff0c\u5206\u6790\u672a\u6765\u60a3\u4e0a\u67d0\u79cd\u75be\u75c5\u7684\u51e0\u7387\u3002\u4f46\u6700\u65b0\u7814\u7a76\u6307\u51fa\uff0c\u5373\u4f7f\u68c0\u6d4b\u7ed3\u679c\u5448\u9634\u6027\uff0c\u4eba\u4eec\u4e5f\u4e0d\u80fd\u5b8c\u5168\u653e\u677e\u8b66\u60d5\uff0c\u56e0\u4e3a\u8fd9\u53ef\u80fd\u662f\u201c\u865a\u5047\u7684\u5b89\u6170\u201d\u3002\n\n[Photo/IC]\n\nConsumer genetic tests could be giving false reassurance to those at heightened risk of cancers, according to findings presented at an international conference last week.\n\n\u4e0a\u5468\u4e00\u6b21\u56fd\u9645\u4f1a\u8bae\u4e0a\u516c\u5e03\u7684\u7814\u7a76\u7ed3\u679c\u663e\u793a\uff0c\u6d88\u8d39\u8005\u57fa\u56e0\u6d4b\u8bd5\u53ef\u80fd\u4f1a\u7ed9\u90a3\u4e9b\u764c\u75c7\u98ce\u9669\u66f4\u9ad8\u7684\u4eba\u5e26\u6765\u865a\u5047\u7684\u5b89\u6170\u3002\n\nThe study, by clinical genetic testing company Invitae, revealed that tests for breast and bowel cancer risk by direct-to-consumer companies such as 23andMe give negative results to the vast majority of those carrying DNA mutations in the genes under investigation.\n\n\u8fd9\u9879\u7531\u4e34\u5e8a\u57fa\u56e0\u68c0\u6d4b\u516c\u53f8Invitae\u5f00\u5c55\u7684\u7814\u7a76\u663e\u793a\uff0c23andMe\u7b49\u76f4\u63a5\u9762\u5411\u6d88\u8d39\u8005\u7684\u516c\u53f8\u5bf9\u4e73\u817a\u764c\u548c\u80a0\u764c\u98ce\u9669\u7684\u68c0\u6d4b\u663e\u793a\uff0c\u7edd\u5927\u591a\u6570\u643a\u5e26\u53d7\u6d4b\u57fa\u56e0DNA\u7a81\u53d8\u7684\u4eba\u68c0\u6d4b\u7ed3\u679c\u90fd\u662f\u9634\u6027\u7684\u3002\n\n\u201cThese tests should not be taken at face value at all, whether they are positive or negative,\u201d said Edward Esplin from Invitae ahead of the annual meeting of the American Society of Human Genetics in Houston, Texas.\n\n\u5728\u7f8e\u56fd\u4eba\u7c7b\u9057\u4f20\u5b66\u5b66\u4f1a\u4e8e\u5fb7\u514b\u8428\u65af\u5dde\u4f11\u65af\u987f\u53ec\u5f00\u5e74\u5ea6\u4f1a\u8bae\u4e4b\u524d\uff0c\u6765\u81eaInvitae\u7684\u7231\u5fb7\u534e\u00b7\u57c3\u65af\u666e\u6797\u8bf4\uff1a\u201c\u8fd9\u4e9b\u68c0\u6d4b\u4e0d\u5e94\u8be5\u53ea\u770b\u8868\u9762\u4ef7\u503c\uff0c\u65e0\u8bba\u68c0\u6d4b\u7ed3\u679c\u662f\u9633\u6027\u8fd8\u662f\u9634\u6027\u3002\u201d\n\nface value\uff1a\u8868\u9762\u4ef7\u503c\n\n\u201cThe data really underscores that there needs to be increased awareness that results from this type of screening may not be wrong but they\u2019re woefully incomplete.\u201d\n\n\u201c\u7814\u7a76\u6570\u636e\u5f3a\u8c03\u7684\u662f\uff0c\u4eba\u4eec\u9700\u8981\u8ba4\u8bc6\u5230\uff0c\u8fd9\u79cd\u68c0\u6d4b\u7684\u7ed3\u679c\u53ef\u80fd\u4e0d\u4f1a\u662f\u9519\u8bef\u7684\uff0c\u4f46\u9057\u61be\u7684\u662f\uff0c\u5b83\u4eec\u662f\u4e0d\u5b8c\u6574\u7684\u3002\u201d\n\nwoefully [\u02c8w\u0259\u028af\u0259li]\uff1aadv.\u60b2\u4f24\u5730\uff1b\u4e0d\u5e78\u5730\n\n[Photo/VCG]\n\nThe research also showed that those from Asian and African-American backgrounds were more likely to carry mutations that were not designed to be detected by the consumer tests.\n\n\u8fd9\u9879\u7814\u7a76\u8fd8\u8868\u660e\uff0c\u6709\u4e9a\u88d4\u548c\u975e\u6d32\u88d4\u8840\u7edf\u7684\u7f8e\u56fd\u4eba\u66f4\u6709\u53ef\u80fd\u643a\u5e26\u7a81\u53d8\u57fa\u56e0\uff0c\u800c\u6d88\u8d39\u8005\u6d4b\u8bd5\u65e0\u6cd5\u68c0\u6d4b\u5230\u8fd9\u4e9b\u7a81\u53d8\u57fa\u56e0\u3002\n\nThe research focused on DNA-based tests relating to breast, ovarian and bowel cancer that were recently approved by the US Food and Drug Administration.\n\n\u8fd9\u9879\u7814\u7a76\u7684\u91cd\u70b9\u662f\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u6700\u8fd1\u6279\u51c6\u7684\u4e0e\u4e73\u817a\u764c\u3001\u5375\u5de2\u764c\u548c\u80a0\u764c\u76f8\u5173\u7684DNA\u68c0\u6d4b\u3002\n\nThe tests operate by a subject sending a DNA swab in the post for analysis and then receiving results with information about how their genetics could influence their health.\n\n\u6d4b\u8bd5\u662f\u8fd9\u6837\u8fdb\u884c\u7684\uff1a\u53d7\u8bd5\u8005\u5bc4\u9001DNA\u6837\u672c\u7528\u4e8e\u5206\u6790\uff0c\u7136\u540e\u6536\u5230\u6709\u5173\u57fa\u56e0\u5bf9\u5065\u5eb7\u5f71\u54cd\u7684\u68c0\u6d4b\u7ed3\u679c\u3002\n\nIn the case of breast and ovarian cancer, the FDA has approved a screening test for three specific mutations on the BRCA1 and BRCA2 genes, which are most common in people of Ashkenazi Jewish heritage. However, these mutations are rare in people from other backgrounds.\n\n\u5c31\u4e73\u817a\u764c\u548c\u5375\u5de2\u764c\u800c\u8a00\uff0cFDA\u5df2\u7ecf\u6279\u51c6\u4e86\u4e00\u9879\u9488\u5bf9BRCA1\u548cBRCA2\u57fa\u56e0\u4e09\u79cd\u7279\u5b9a\u7a81\u53d8\u7684\u7b5b\u67e5\u6d4b\u8bd5\uff0c\u8fd9\u4e24\u79cd\u7a81\u53d8\u5728\u5fb7\u7cfb\u72b9\u592a\u4eba\u4e2d\u6700\u4e3a\u5e38\u89c1\u3002\u7136\u800c\uff0c\u8fd9\u4e9b\u7a81\u53d8\u5728\u5176\u4ed6\u8840\u7edf\u7684\u4eba\u8eab\u4e0a\u5f88\u5c11\u89c1\u3002\n\nAshkenazi[\u02cc\u00e6\u0283k\u0259\u02c8n\u0251\u02d0zi]\uff1an.\u5fb7\u7cfb\u72b9\u592a\u4eba\n\nSimilarly, for bowel cancer, 23andMe offers FDA-authorised tests for two mutations, which are most common among individuals of northern European ancestry. The company explains the limitations of these tests to consumers and on its website.\n\n\u7c7b\u4f3c\u5730\uff0c\u5bf9\u4e8e\u80a0\u764c\uff0c23andMe\u516c\u53f8\u63d0\u4f9bFDA\u6388\u6743\u7684\u4e24\u79cd\u57fa\u56e0\u7a81\u53d8\u68c0\u6d4b\uff0c\u8fd9\u5728\u5317\u6b27\u8840\u7edf\u7684\u4eba\u4e2d\u6700\u4e3a\u5e38\u89c1\u3002\u8be5\u516c\u53f8\u5728\u5176\u7f51\u7ad9\u4e0a\u5411\u6d88\u8d39\u8005\u89e3\u91ca\u4e86\u8fd9\u4e9b\u6d4b\u8bd5\u7684\u5c40\u9650\u6027\u3002\n\nEsplin said that despite this, consumers could be wrongly reassured by a negative result.\n\n\u57c3\u65af\u666e\u6797\u8868\u793a\uff0c\u5c3d\u7ba1\u5982\u6b64\uff0c\u6d88\u8d39\u8005\u4ecd\u53ef\u80fd\u88ab\u9634\u6027\u7ed3\u679c\u9519\u8bef\u5730\u6253\u6d88\u7591\u8651\u3002\n\nThe study analysed the DNA of 270,806 patients who had been referred by healthcare providers for testing of the MUTYH gene, and 119,328 who had been referred for BRCA1/2 genetic testing.\n\n\u8fd9\u9879\u7814\u7a76\u5206\u6790\u4e86270806\u540d\u88ab\u533b\u7597\u673a\u6784\u63a8\u8350\u8fdb\u884cMUTYH\u57fa\u56e0\u68c0\u6d4b\u60a3\u8005\u7684DNA\uff0c\u4ee5\u53ca119328\u540d\u88ab\u63a8\u8350\u8fdb\u884cBRCA1/2\u57fa\u56e0\u68c0\u6d4b\u60a3\u8005\u7684DNA\u3002\n\nIt showed that for both tests, the majority of those carrying mutations would not be spotted, which Invitae describes as a \u201cclinical false-negative result\u201d.\n\n\u7ed3\u679c\u663e\u793a\uff0c\u5728\u8fd9\u4e24\u79cd\u68c0\u6d4b\u4e2d\uff0c\u5927\u591a\u6570\u643a\u5e26\u7a81\u53d8\u7684\u4eba\u90fd\u6ca1\u6709\u88ab\u53d1\u73b0\uff0cInvitae\u5c06\u5176\u63cf\u8ff0\u4e3a\u201c\u4e34\u5e8a\u5047\u9634\u6027\u7ed3\u679c\u201d\u3002\n\nFor MUYTH, 40% of individuals with mutations in both copies of their MUTYH genes \u2013 consistent with an almost 100% lifetime risk of bowel cancer \u2013 had different mutations to those screened for in the FDA-approved test. This figure rose to 100% for those from Asian backgrounds and 75% for African-Americans.\n\n\u5bf9\u4e8eMUYTH\u57fa\u56e0\uff0c\u5728\u643a\u5e26\u6709\u4e24\u79cdMUTYH\u57fa\u56e0\u62f7\u8d1d\u7a81\u53d8\u7684\u4eba\u4e2d\uff0c\u670940%\u7684\u4eba\u7684\u7a81\u53d8\u4e0eFDA\u6388\u6743\u68c0\u6d4b\u5230\u7684\u7a81\u53d8\u4e0d\u540c\u3002\u8fd9\u4e2a\u6570\u5b57\u5728\u4e9a\u88d4\u7f8e\u56fd\u4eba\u4e2d\u4e0a\u5347\u5230100%\uff0c\u5728\u975e\u6d32\u88d4\u7f8e\u56fd\u4eba\u4e2d\u4e0a\u5347\u523075%\u3002\u643a\u5e26\u6709\u8fd9\u4e24\u79cd\u57fa\u56e0\u7a81\u53d8\u7684\u4eba\u4e00\u751f\u4e2d\u7f79\u60a3\u80a0\u764c\u7684\u98ce\u9669\u51e0\u4e4e\u662f100%\u3002\n\nFor BRCA genes, 94% of non-Ashkenazi Jewish individuals and 19% of those of Ashkenazi heritage had a mutation that would be missed. Again, the figures were highest for those of Asian (98%) and African-American (99%) ancestry.\n\n\u5bf9\u4e8eBRCA\u57fa\u56e0\uff0c94%\u7684\u975e\u5fb7\u7cfb\u72b9\u592a\u4eba\u548c19%\u7684\u5fb7\u7cfb\u72b9\u592a\u4eba\u643a\u5e26\u6709\u53ef\u80fd\u88ab\u9057\u6f0f\u7684\u57fa\u56e0\u7a81\u53d8\u3002\u540c\u6837\uff0c\u4e9a\u88d4\uff0898%\uff09\u548c\u975e\u88d4\uff0899%\uff09\u7684\u6bd4\u4f8b\u6700\u9ad8\u3002\n\n\u201cA clinical false-negative result can be incorrectly reassuring, excluding a patient from receiving the preventive care they need based on their risk,\u201d he added. \u201cIt could be the difference between preventing cancer and developing cancer.\u201d\n\n\u4ed6\u8865\u5145\u8bf4\uff1a\u201c\u4e34\u5e8a\u5047\u9634\u6027\u7684\u7ed3\u679c\u53ef\u80fd\u662f\u8bef\u5bfc\u6027\u7684\u5b89\u6170\uff0c\u4f7f\u4eba\u4eec\u4e0d\u518d\u63a5\u53d7\u9700\u8981\u57fa\u4e8e\u98ce\u9669\u800c\u8fdb\u884c\u7684\u9884\u9632\u6027\u6cbb\u7597\u3002\u4eba\u4eec\u53ef\u80fd\u4f1a\u60a3\u4e0a\u539f\u672c\u53ef\u4ee5\u9884\u9632\u7684\u764c\u75c7\u3002\u201d\n\nIn response to the findings, 23andMe said in a statement: \u201cThe claims made by a competitor that we are returning \u2018clinical false negatives\u2019 is incorrect and a false characterisation of 23andMe\u2019s test. Our test is extremely accurate. As part of the FDA authorisation process we\u2019ve demonstrated over 99% accuracy for the variants we test for in our health product.\u201d\n\n\u9488\u5bf9\u8fd9\u4e9b\u53d1\u73b0\uff0c23andMe\u5728\u4e00\u4efd\u58f0\u660e\u4e2d\u8868\u793a\uff1a\u201c\u7ade\u4e89\u5bf9\u624b\u58f0\u79f0\u6211\u4eec\u6b63\u5c06\u2018\u4e34\u5e8a\u5047\u9634\u6027\u7ed3\u679c\u2019\u9000\u56de\u662f\u5047\u6d88\u606f\uff0c\u5176\u5bf9\u672c\u516c\u53f8\u6d4b\u8bd5\u7684\u7279\u5f81\u63cf\u8ff0\u4e5f\u662f\u9519\u8bef\u7684\u3002\u6211\u4eec\u7684\u6d4b\u8bd5\u975e\u5e38\u51c6\u786e\u3002\u4f5c\u4e3aFDA\u6388\u6743\u68c0\u6d4b\u8fc7\u7a0b\u7684\u4e00\u90e8\u5206\uff0c\u6211\u4eec\u5df2\u7ecf\u8bc1\u660e\uff0c\u6211\u4eec\u7684\u5065\u5eb7\u4ea7\u54c1\u57fa\u56e0\u53d8\u5f02\u6d4b\u8bd5\u51c6\u786e\u6027\u8d85\u8fc799%\u3002\u201d\n\nThe company said it makes clear to customers that it tests only for certain genetic variants and that customers should not forgo any recommended testing based on 23andMe results. \u201c23andMe is not a diagnostic test,\u201d the company said. \u201cIf an individual has a family history of cancer or other indications for clinical testing we always recommend consulting a healthcare provider first.\u201d\n\n\u8be5\u516c\u53f8\u8868\u793a\uff0c\u5df2\u5411\u5ba2\u6237\u660e\u786e\u8868\u793a\uff0c\u53ea\u68c0\u6d4b\u67d0\u4e9b\u57fa\u56e0\u53d8\u5f02\uff0c\u5ba2\u6237\u4e0d\u5e94\u653e\u5f03\u4efb\u4f55\u57fa\u4e8e23andMe\u7ed3\u679c\u7684\u63a8\u8350\u68c0\u6d4b\u3002\u8be5\u516c\u53f8\u8868\u793a\uff1a\u201c\u8fd9\u4e0d\u662f\u8bca\u65ad\u6d4b\u8bd5\u3002\u5982\u679c\u4e00\u4e2a\u4eba\u6709\u764c\u75c7\u5bb6\u65cf\u53f2\u6216\u5176\u4ed6\u4e34\u5e8a\u68c0\u6d4b\u7684\u9002\u5e94\u75c7\uff0c\u6211\u4eec\u4e00\u76f4\u5efa\u8bae\u9996\u5148\u54a8\u8be2\u533b\u7597\u673a\u6784\u3002\u201d\n\nforgo[f\u0254\u02d0\u02c8\u0261\u0259\u028a]\uff1avi.\u653e\u5f03\uff1b\u505c\u6b62\n\ndiagnostic[\u02ccda\u026a\u0259\u0261\u02c8n\u0252st\u026ak]\uff1aadj.\u8bca\u65ad\u7684\n\nProf Anneke Lucassen, a clinical geneticist at the University of Southampton, said that, in her experience, non-specialists would be likely to wrongly interpret negative results as an \u201call-clear\u201d.\n\n\u5357\u5b89\u666e\u987f\u5927\u5b66\u4e34\u5e8a\u9057\u4f20\u5b66\u5bb6\u5b89\u59ae\u514b\u2022\u5362\u5361\u68ee\u6559\u6388\u8868\u793a\uff0c\u6839\u636e\u5979\u7684\u7ecf\u9a8c\uff0c\u975e\u4e13\u4e1a\u4eba\u58eb\u5f88\u53ef\u80fd\u4f1a\u9519\u8bef\u5730\u5c06\u9634\u6027\u7ed3\u679c\u89e3\u8bfb\u4e3a\u201c\u6ca1\u6709\u98ce\u9669\u201d\u3002\n\n\u201cI do think the \u2018false-negative\u2019 rate is an issue, not necessarily through the companies\u2019 fault but through low general awareness,\u201d she said. \u201cMost people who come to clinic ask: \u2018Have I got the gene for breast cancer?\u2019 and imagine it\u2019s a single test, not that the test involves looking through around 20,000 letters of the genetic code to see if any one of them might be different.\u201d\n\n\u5979\u8bf4\uff1a\u201c\u6211\u786e\u5b9e\u8ba4\u4e3a\u5047\u9634\u6027\u7387\u662f\u4e2a\u95ee\u9898\uff0c\u8fd9\u4e0d\u4e00\u5b9a\u662f\u7531\u4e8e\u516c\u53f8\u7684\u5931\u8bef\uff0c\u800c\u662f\u7531\u4e8e\u4eba\u4eec\u7684\u666e\u904d\u610f\u8bc6\u4e0d\u5f3a\u3002\u5927\u591a\u6570\u6765\u8bca\u6240\u7684\u4eba\u4f1a\u95ee\uff1a\u2018\u6211\u6709\u4e73\u817a\u764c\u7684\u57fa\u56e0\u5417\uff1f\u2019\u60f3\u8c61\u4e00\u4e0b\uff0c\u8fd9\u662f\u4e00\u4e2a\u5355\u4e00\u7684\u6d4b\u8bd5\uff0c\u800c\u4e0d\u662f\u901a\u8fc7\u68c0\u67e5\u5927\u7ea6\u4e24\u4e07\u4e2a\u57fa\u56e0\u5e8f\u5217\u7f16\u7801\u6765\u5224\u65ad\u54ea\u4e9b\u6709\u6240\u4e0d\u540c\u3002\u201d\n\n\u82f1\u6587\u6765\u6e90\uff1a\u536b\u62a5\n\n\u7ffb\u8bd1&\u7f16\u8f91\uff1ayaning", "description": "\u6700\u65b0\u7814\u7a76\u6307\u51fa\uff0c\u5373\u4f7f\u68c0\u6d4b\u7ed3\u679c\u5448\u9634\u6027\uff0c\u4eba\u4eec\u4e5f\u4e0d\u80fd\u5b8c\u5168\u653e\u677e\u8b66\u60d5\uff0c\u56e0\u4e3a\u8fd9\u53ef\u80fd\u662f\u201c\u865a\u5047\u7684\u5b89\u6170\u201d\u3002", "authors": [], "top_image": "https://img2.chinadaily.com.cn/images/201910/28/5db67002a310cf3e97a336d1.jpeg", "published_at": "2019-10-28"}